| |
|
|
|
Cytosorbents Corporation  
|
|
6.29 -0.33 (-0.05%) |
06-18 16:00 |
|
Open: |
6.68 |
Pre close: |
6.62 |
Target:
|
7.81 
|
|
High: |
6.68 |
Low: |
5.97 |
Resistance:
|
6.69
7.21
|
|
Volume: |
181,336 |
Market Cap: |
203M |
Support:
|
5.84
4.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.18
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
6.43 |
Signal(12,26,9): |
-0.21 |
|
MA(100): |
7.34 |
Stochastic Oscillator |
%K(14,3):
|
38.98 |
|
MA(250): |
9.44 |
%D(3): |
25.41 |
|
Average Volume(K) |
3-Month: |
11845
|
52-Week |
High:
|
14.95 |
|
10-Days: |
10501 |
Low: |
5.84 |
|
RSI |
RSI(14):
|
45.22 |
Change(%): |
-44.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.560 |
Return on Equity (ttm) |
-135.7 |
Shares Out. (M) |
32.25 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-67.3 |
Shares Float (M) |
13.03 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
5.4 |
% Held by Institutions |
41.50 |
|
Forward EPS |
-0.120 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
13.640 |
EBITDA (p.s.) |
0.000 |
P/E |
-11.23 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.46 |
|
Profit Margin |
-94.37 |
Operating Cash Flow
(M) |
-12.87 |
P/S |
277880128.00 |
|
Operating Margin |
-73.64 |
Levered Free Cash Flow
(M) |
-8.83 |
P/CF |
-15.76 |
|
|
|
|
|
|
